Revolution Medicines: Take The Win And Sell Following Large Move Sparked By Buyout Rumors [Seeking Alpha]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Seeking Alpha
Merck's rumored interest in a deal rekindled interest in shares. RVMD's pipeline centers on Daraxonrasib (RMC-6236), with three advanced programs targeting pancreatic ductal adenocarcinoma and one for non-small cell lung cancer. Previous 'Sell' rating proved premature, as RVMD rallied over 200% since the last article, highlighting high volatility and event-driven sentiment. If the acquisition narrative fades, RVMD's valuation would hinge on pipeline execution, particularly in PDAC indications. courtneyk/E+ via Getty Images This is my second Revolution Medicines ( RVMD ) article after 04/2025's "Revolution Medicines: Overpriced RAS-Addicted Cancers Maven". In Maven I rated Revolution as a "Sell". It has since increased by 250%. Enough said, obviously a horrendous call on my This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of ABBV, GILD either through stock ownership, options, or other derivatives. I wrote this article m
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines (NASDAQ:RVMD) was given a new $143.00 price target on by analysts at Mizuho.MarketBeat
- JPM 26: Day 1 – drug prices and policy changes drive the agenda [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines declines to comment on M&A speculation at conference [Seeking Alpha]Seeking Alpha
- JPM26: Eli Lilly reportedly eyes €15bn takeover of Abivax [Yahoo! Finance]Yahoo! Finance
- AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense [Yahoo! Finance]Yahoo! Finance
RVMD
Earnings
- 11/5/25 - Miss
RVMD
Sec Filings
- 1/9/26 - Form 4
- 1/9/26 - Form 4
- 1/7/26 - Form 144
- RVMD's page on the SEC website